Back to list

The 1289-0032 Research Study: Are your thoughts tangled?

University of North Carolina at Chapel Hill


Are Your Thoughts Tangled? You're not sure how or why it happened, but you are aware of instances lately when it felt like you had no control over your thoughts. You couldn't think clearly or concentrate, and you may have even heard or seen things that other people didn't. While these were unsettling times, you eventually regained control of your thoughts. Still, you may be concerned about whether it will happen again and if it could be a sign of a more serious mental health condition. Because you and others have experienced symptoms like these, local doctors are conducting the 1289-0032 Research Study. In this study, doctors want to evaluate the safety and effectiveness of an investigational drug and compare it to placebo, which looks like the investigational drug but contains no active medication. The investigational drug is not approved to treat any mental health or medical condition. The results of this study will provide more information about the investigational drug and whether it could one day be used to help people who have experienced symptoms similar to yours.


Mental Health


Drug or Biologic



16 - 30 years


Study Population

Patients eligible for this study may have experienced symptoms such as: • Trouble thinking clearly or concentrating • Believing or hearing things that others do not • Losing control of their thoughts • Feeling nervous or anxious • Feeling that others are "out to get" them • Having trouble with family and friends • Having thoughts that scare them or the people around them • Having trouble at work or school


Diana Perkins
Psychiatry - Center of Excellence - Outreach and Support Intervention Services (OASIS)

For questions, contact:

Jennifer Nieri, LCSW
(877) 774-6319
Visit Website

Recruitment Period End

September 30, 2021


Primary Location
UNC School of Medicine Med Wings
320 Emergency Room Dr, Chapel Hill, NC 27599, USA

Study Qualifications

Gender Any

Age Range 16 - 30 years

Participant qualification(s) You may be able to participate in this study if you: • Are 16 to 30 years of age • Are experiencing one or more of the symptoms listed above • Have not been diagnosed with schizophrenia or related disorders, bipolar disorder I, or major depressive disorder with psychotic symptoms • Are not taking a medication called clozapine

Not eligible if: The study staff will review additional eligibility requirements with you.

Number of Visits

    » 15 In person visit(s)

    1 screening visit, 14 other visits involving various other assessments

    » 10 Remote visit(s)

    10 phone visits involving phone surveys

Participation Period

56 weeks


up to $1800

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.